TrialPanorama/TrialPanorama-database huggingface dataset:
Study 31167890 — Safety Biomarker (SAF): Hemoglobin scavenger receptor
Genes: CD163; M130
Study 31167965 — Predictive Biomarker (PRD): COL7A1 mRNA
Genes: COL7A1
Study 31167965 — Monitoring Biomarker (MOI): Complement C7
Genes: C7
Study 31168381 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 31168384 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 31168392 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 31170954 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 31171735 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 31171735 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 31171735 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 31171916 — Surrogate Endpoint (SUR): Blood pressure
Study 31172178 — Predictive Biomarker (PRD): FGF21 mRNA
Genes: FGF21; UNQ3115/PRO10196
Study 31174106 — Predictive Biomarker (PRD): LAMA1 mRNA
Genes: LAMA1; LAMA
Study 31174106 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 31177537 — Pharmacodynamic Biomarker (PDY): Histone acetylation
Study 31177556 — Pharmacodynamic Biomarker (PDY): Guanine nucleotide exchange factor C9orf72
Genes: C9orf72; DENND9; DENNL72
Study 31177556 — Predictive Biomarker (PRD): C9 mRNA
Genes: C9
Study 31178349 — Predictive Biomarker (PRD): GTSE1 mRNA
Genes: GTSE1
Study 31178349 — Predictive Biomarker (PRD): DDB1 mRNA
Genes: DDB1; XAP1
Study 31178349 — Predictive Biomarker (PRD): MLH3 mRNA
Genes: MLH3
Study 31178349 — Predictive Biomarker (PRD): DNA excision repair protein ERCC-1
Genes: ERCC1
Study 31178349 — Predictive Biomarker (PRD): XPAC mRNA
Genes: XPA; XPAC
Study 31179061 — Predictive Biomarker (PRD): TF mRNA
Genes: TF; PRO1400
Study 31179079 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 31179103 — Surrogate Endpoint (SUR): Serum creatinine
Study 31179499 — Surrogate Endpoint (SUR): Blood pressure
Study 31179503 — Surrogate Endpoint (SUR): Bone mineral density
Study 31182031 — Predictive Biomarker (PRD): C1QTNF3 mRNA
Genes: C1QTNF3; CTRP3; UNQ753/PRO1484
Study 31182436 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study 31183189 — Predictive Biomarker (PRD): Epithelial cadherin
Genes: CDH1; CDHE; UVO
Study 31183463 — Predictive Biomarker (PRD): TKTL1 mRNA
Genes: TKTL1; TKR; TKT2
Study 31183463 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study 31183813 — Surrogate Endpoint (SUR): Hematologic response
Study 31183877 — Predictive Biomarker (PRD): CD47 mRNA
Genes: CD47; MER6
Study 31183877 — Predictive Biomarker (PRD): ABO mRNA
Genes: ABO
Study 31183877 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 31187454 — Predictive Biomarker (PRD): NPC1 mRNA
Genes: NPC1
Study 31191000 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study 31191000 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 31191007 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 31191190 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 31191688 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 31191688 — Predictive Biomarker (PRD): PTPRC mRNA
Genes: PTPRC; CD45
Study 31191688 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 31191908 — Predictive Biomarker (PRD): DPT mRNA
Genes: DPT
Study 31191908 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 31191908 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 31192894 — Predictive Biomarker (PRD): SRY mRNA
Genes: SRY; TDF
Study 31192910 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 31193613 — Predictive Biomarker (PRD): PDXP mRNA
Genes: PDXP; CIN; PLP; PLPP
Study 31193824 — Predictive Biomarker (PRD): ASL mRNA
Genes: ASL
Study 31194225 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 31194228 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study 31194247 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 31194611 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 31194764 — Predictive Biomarker (PRD): ILK mRNA
Genes: ILK; ILK1; ILK2
Study 31194872 — Predictive Biomarker (PRD): PPARG mRNA
Genes: PPARG; NR1C3
Study 31194872 — Predictive Biomarker (PRD): LMNA mRNA
Genes: LMNA; LMN1
Study 31194884 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study 31195991 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 31196179 — Predictive Biomarker (PRD): KL mRNA
Genes: KL
Study 31196179 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 31196179 — Safety Biomarker (SAF): Hemoglobin scavenger receptor
Genes: CD163; M130
Study 31197699 — Predictive Biomarker (PRD): EIF2AK1 mRNA
Genes: EIF2AK1; HRI; KIAA1369; PRO1362
Study 31197699 — Predictive Biomarker (PRD): CAPS mRNA
Genes: CAPS
Study 31198061 — Predictive Biomarker (PRD): RAPH1 mRNA
Genes: RAPH1; ALS2CR18; ALS2CR9; KIAA1681; LPD; PREL2; RMO1
Study 31198489 — Safety Biomarker (SAF): BCHE
Genes: E1
Study 31199334 — Surrogate Endpoint (SUR): Serum creatinine
Study 31199335 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 31199335 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 31199335 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study 31200729 — Predictive Biomarker (PRD): PAM mRNA
Genes: PAM
Study 31201085 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study 31201085 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study 31202772 — Predictive Biomarker (PRD): CNR1 mRNA
Genes: CNR1; CNR
Study 31207465 — Predictive Biomarker (PRD): PSEN1 mRNA
Genes: PSEN1; AD3; PS1; PSNL1
Study 31208944 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 31208955 — Predictive Biomarker (PRD): PAFAH1B1 mRNA
Genes: PAFAH1B1; LIS1; MDCR; MDS; PAFAHA
Study 31212162 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 31212997 — Safety Biomarker (SAF): miR-16
Study 31213500 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study 31213500 — Predictive Biomarker (PRD): CSF1R mRNA
Genes: CSF1R; FMS
Study 31213500 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study 31214997 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 31215264 — Predictive Biomarker (PRD): APEX1 mRNA
Genes: APEX1; APE; APE1; APEX; APX; HAP1; REF1
Study 31216297 — Surrogate Endpoint (SUR): Blood pressure
Study 31217161 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 31217479 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 31217479 — Pharmacodynamic Biomarker (PDY): Tropomyosin-related kinase A
Genes: NTRK1; MTC; TRK; TRKA
Study 31217993 — Monitoring Biomarker (MOI): Angiopoietin-1
Genes: ANGPT1; KIAA0003
Study 31218013 — Surrogate Endpoint (SUR): Serum creatinine
Study 31220400 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 31220640 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 31222720 — Predictive Biomarker (PRD): HBEGF mRNA
Genes: HBEGF; DTR; DTS; HEGFL
Study 31222722 — Pharmacodynamic Biomarker (PDY): Mitochondrial membrane potential
Study 31223191 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 31225610 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 31225870 — Predictive Biomarker (PRD): ATG7 mRNA
Genes: ATG7; APG7L
Study 31225870 — Predictive Biomarker (PRD): RARRES2 mRNA
Genes: RARRES2; TIG2
Study 31225872 — Predictive Biomarker (PRD): HSD11B2 mRNA
Genes: HSD11B2; HSD11K; SDR9C3
Study 31230508 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 31230614 — Predictive Biomarker (PRD): SLN mRNA
Genes: SLN
Study 31231276 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 31231276 — Safety Biomarker (SAF): BDNF
Study 31231785 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 31231785 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 31233392 — Surrogate Endpoint (SUR): Blood pressure
Study 31234786 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 31235405 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 31235405 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 31235441 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 31235441 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 31235441 — Predictive Biomarker (PRD): Hormone receptor
Study 31235483 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 31235483 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 31235483 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study 31235483 — Predictive Biomarker (PRD): MMP7 mRNA
Genes: MMP7; MPSL1; PUMP1
Study 31235963 — Predictive Biomarker (PRD): WT1 mRNA
Genes: WT1
Study 31236579 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study 31236601 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 31236809 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 31236847 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study 31237206 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study 31239315 — Predictive Biomarker (PRD): CAP1 mRNA
Genes: CAP1; CAP
Study 31239857 — Predictive Biomarker (PRD): ACAT1 mRNA
Genes: ACAT1; ACAT; MAT
Study 31240302 — Predictive Biomarker (PRD): CLDN18 mRNA
Genes: CLDN18; UNQ778/PRO1572
Study 31240688 — Predictive Biomarker (PRD): IGFBP7 mRNA
Genes: IGFBP7; MAC25; PSF
Study 31242023 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 31242023 — Predictive Biomarker (PRD): Hypoxia-inducible factor 1-alpha
Genes: HIF1A; BHLHE78; MOP1; PASD8
Study 31242023 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 31245054 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 31246589 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 31246589 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 31249371 — Surrogate Endpoint (SUR): Blood pressure
Study 31249989 — Predictive Biomarker (PRD): APEX1 mRNA
Genes: APEX1; APE; APE1; APEX; APX; HAP1; REF1
Study 31250829 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 31251543 — Predictive Biomarker (PRD): FST mRNA
Genes: FST
Study 31253124 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 31253540 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study 31253596 — Predictive Biomarker (PRD): MDM2 mRNA
Genes: MDM2
Study 31253596 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 31253624 — Predictive Biomarker (PRD): CPE mRNA
Genes: CPE
Study 31254057 — Predictive Biomarker (PRD): LAD1 mRNA
Genes: LAD1; LAD
Study 31254223 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 31256779 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 31256779 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 31257724 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 31258922 — Surrogate Endpoint (SUR): Forced vital capacity
Study 31261514 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 31262327 — Predictive Biomarker (PRD): PPBP mRNA
Genes: PPBP; CTAP3; CXCL7; SCYB7; TGB1; THBGB1
Study 31262327 — Predictive Biomarker (PRD): THBS1 mRNA
Genes: THBS1; TSP; TSP1
Study 31262327 — Predictive Biomarker (PRD): LYVE1 mRNA
Genes: LYVE1; CRSBP1; HAR; XLKD1; UNQ230/PRO263
Study 31262327 — Predictive Biomarker (PRD): IGF2 mRNA
Genes: IGF2; PP1446
Study 31262783 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 31263727 — Safety Biomarker (SAF): Hyaluronic acid
Study 31263960 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 31266056 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study 31266741 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 31267973 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 31269208 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 31269208 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 31269208 — Surrogate Endpoint (SUR): Bone mineral density
Study 31269546 — Surrogate Endpoint (SUR): Annualized growth velocity
Study 31269854 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study 31269910 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 31269910 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study 31269910 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 31269910 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study 31269910 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 31270080 — Predictive Biomarker (PRD): PTPN2 mRNA
Genes: PTPN2; PTPT
Study 31270080 — Predictive Biomarker (PRD): TLX1 mRNA
Genes: TLX1; HOX11; TCL3
Study 31270080 — Pharmacodynamic Biomarker (PDY): Interleukin 7 receptor alpha
Genes: IL7R
Study 31270080 — Predictive Biomarker (PRD): WT1 mRNA
Genes: WT1
Study 31270080 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study 31270103 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 31270178 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study 31270738 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 31271463 — Monitoring Biomarker (MOI): HBV DNA
Study 31272391 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 31274114 — Predictive Biomarker (PRD): CIT mRNA
Genes: CIT; CRIK; KIAA0949; STK21
Study 31277699 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 31277699 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study 31277699 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 31277699 — Predictive Biomarker (PRD): AKT1 mRNA
Genes: AKT1; PKB; RAC
Study 31277699 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study 31278103 — Surrogate Endpoint (SUR): Bone mineral density
Study 31278692 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 31278892 — Surrogate Endpoint (SUR): Blood pressure
Study 31279304 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study 31279871 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 31280289 — Surrogate Endpoint (SUR): Blood pressure
Study 31280390 — Monitoring Biomarker (MOI): HBV DNA
Study 31282597 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 31282597 — Safety Biomarker (SAF): miR-146a
Genes: MIR146A
Study 31282597 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-150
Genes: MIR150
Study 31282597 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): miR-124
Study 31282597 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-143
Genes: MIR143
Study 31282597 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 31285780 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 31285780 — Predictive Biomarker (PRD): FGF2 mRNA
Genes: FGF2; FGFB
Study 31285780 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 31285871 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 31289029 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study 31289819 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 31289819 — Predictive Biomarker (PRD): C1QA mRNA
Genes: C1QA
Study 31289819 — Predictive Biomarker (PRD): CR1 mRNA
Genes: CR1; C3BR
Study 31291985 — Predictive Biomarker (PRD): ARHGEF5 mRNA
Genes: ARHGEF5; TIM
Study 31291985 — Predictive Biomarker (PRD): CD47 mRNA
Genes: CD47; MER6
Study 31291985 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 31292728 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 31293437 — Safety Biomarker (SAF): BDNF
Study 31294762 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 31296423 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 31296923 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 31297636 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 31297636 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): CCR2 mRNA
Genes: CCR2; CMKBR2
Study 31297647 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 31297647 — Monitoring Biomarker (MOI): Cell-free DNA
Study 31297947 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 31298286 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 31299005 — Predictive Biomarker (PRD): ANTXR1 mRNA
Genes: ANTXR1; ATR; TEM8
Study 31299074 — Predictive Biomarker (PRD): CYP2B6 mRNA
Genes: CYP2B6
Study 31299074 — Predictive Biomarker (PRD): NR1I2 mRNA
Genes: NR1I2; PXR
Study 31299246 — Predictive Biomarker (PRD): TSC2
Genes: tuberin; LAM; PPP1R160
Study 31299468 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 31299972 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 31300344 — Safety Biomarker (SAF): CDA
Genes: CDD
Study 31300360 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study 31300820 — Predictive Biomarker (PRD): OAT mRNA
Genes: OAT
Study 31300969 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 31301251 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 31301962 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study 31302044 — Surrogate Endpoint (SUR): Blood pressure
Study 31302344 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study 31303280 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 31303643 — Predictive Biomarker (PRD): PLK4 mRNA
Genes: PLK4; SAK; STK18
Study 31304973 — Predictive Biomarker (PRD): FMR1
Genes: FMRP; FRAXA; MGC87458
Study 31304973 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 31304973 — Safety Biomarker (SAF): BDNF
Study 31307216 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 31307542 — Predictive Biomarker (PRD): MLH1 mRNA
Genes: MLH1; COCA2
Study 31307542 — Predictive Biomarker (PRD): DNA mismatch repair protein MSH2
Genes: MSH2
Study 31307542 — Predictive Biomarker (PRD): Microsatellite instability
Study 31308059 — Predictive Biomarker (PRD): NRG1 mRNA
Genes: NRG1; GGF; HGL; HRGA; NDF; SMDF
Study 31309541 — Predictive Biomarker (PRD): DDIT3 mRNA
Genes: DDIT3; CHOP; CHOP10; GADD153
Study 31310310 — Surrogate Endpoint (SUR): Bone mineral density
Study 31310310 — Surrogate Endpoint (SUR): Serum calcium
Study 31312030 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study 31312536 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study 31312536 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 31312806 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 31313237 — Surrogate Endpoint (SUR): Blood pressure
Study 31315600 — Predictive Biomarker (PRD): NBN mRNA
Genes: NBN; NBS; NBS1; P95
Study 31316836 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 31316836 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 31316836 — Predictive Biomarker (PRD): GLS2 mRNA
Genes: GLS2; GA
Study 31316836 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 31316836 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 31318125 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 31319038 — Predictive Biomarker (PRD): P2RX7 mRNA
Genes: P2RX7
Study 31319498 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 31319851 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 31319977 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 31319994 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 31319994 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study 31319994 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 31320010 — Predictive Biomarker (PRD); Safety Biomarker (SAF): STAR mRNA
Genes: STAR; STARD1
Study 31320356 — Predictive Biomarker (PRD): EP300 mRNA
Genes: EP300; P300
Study 31320356 — Pharmacodynamic Biomarker (PDY): Mismatch negativity
Study 31320445 — Predictive Biomarker (PRD): MVD mRNA
Genes: MVD; MPD
Study 31321442 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 31321485 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 31321875 — Surrogate Endpoint (SUR): Serum creatinine
Study 31321875 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study 31322672 — Surrogate Endpoint (SUR): Bone mineral density
Study 31322702 — Predictive Biomarker (PRD): C-C motif chemokine 7
Genes: CCL7; MCP3; SCYA6; SCYA7
Study 31323075 — Predictive Biomarker (PRD): RALA mRNA
Genes: RALA; RAL
Study 31323705 — Monitoring Biomarker (MOI): HBV DNA
Study 31324189 — Predictive Biomarker (PRD): DSP mRNA
Genes: DSP
Study 31324600 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 31325105 — Surrogate Endpoint (SUR): Forced vital capacity